Allahham, Nour;
Colic, Ines;
Rayner, Melissa LD;
Gurnani, Pratik;
Phillips, James B;
Rahim, Ahad A;
Williams, Gareth R;
(2023)
Advanced Formulation Approaches for Emerging Therapeutic Technologies.
In: Michel, Martin C, (ed.)
Handbook of Experimental Pharmacology.
(pp. 1-23).
Springer Verlag: Berlin, Heidelberg, Germany.
![[thumbnail of Advanced formulation approaches for ATMPs REVISED clean no fields V2.pdf]](https://discovery.ucl.ac.uk/style/images/fileicons/text.png) |
Text
Advanced formulation approaches for ATMPs REVISED clean no fields V2.pdf - Accepted Version Access restricted to UCL open access staff until 23 September 2025. Download (602kB) |
Abstract
In addition to proteins, discussed in the Chapter “Advances in Vaccine Adjuvants: Nanomaterials and Small Molecules”, there are a wide range of alternatives to small molecule active ingredients. Cells, extracellular vesicles, and nucleic acids in particular have attracted increasing research attention in recent years. There are now a number of products on the market based on these emerging technologies, the most famous of which are the mRNA-based vaccines against SARS-COV-2. These advanced therapeutic moieties are challenging to formulate however, and there remain significant challenges for their more widespread use. In this chapter, we consider the potential and bottlenecks for developing further medical products based on these systems. Cells, extracellular vesicles, and nucleic acids will be discussed in terms of their mechanism of action, the key requirements for translation, and how advanced formulation approaches can aid their future development. These points will be presented with selected examples from the literature, and with a focus on the formulations which have made the transition to clinical trials and clinical products.
Archive Staff Only
 |
View Item |
